| |
| |
|
| Insider
Information: |
Monnet Dominique |
| Relationship: |
President and CEO |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
743,708 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,418,882 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
743,708 |
|
|
| Total
Value |
$3,418,882 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -4.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
SVP, Chief Marketing O... |
2015-05-20 |
8,787 |
2015-02-05 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
President and CEO |
2020-12-16 |
734,921 |
2017-09-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PDLI |
PDL Biopharma Inc |
President and CEO |
• – – |
2020-12-16 |
4 |
S |
$2.60 |
$1,300,000 |
D/D |
(500,000) |
734,921 |
0 |
% |
|
| PDLI |
PDL Biopharma Inc |
President and CEO |
• – – |
2020-02-07 |
4 |
D |
$3.51 |
$2,360,493 |
D/D |
(672,505) |
1,234,921 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President and CEO |
• – – |
2020-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,233,766 |
1,907,426 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President and CEO |
• – – |
2019-03-28 |
4/A |
A |
$3.72 |
$1,677,999 |
D/D |
451,075 |
673,660 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President and CEO |
• – – |
2019-03-28 |
4 |
A |
$3.72 |
$1,604,499 |
D/D |
431,317 |
653,902 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President |
• – – |
2018-12-27 |
4 |
D |
$3.02 |
$53,197 |
D/D |
(17,615) |
222,585 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
President |
• – – |
2017-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
240,200 |
240,200 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Marketing Officer |
• – – |
2015-05-20 |
4 |
S |
$162.40 |
$41,574 |
D/D |
(256) |
8,787 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Marketing Officer |
• – – |
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
3,830 |
9,043 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Marketing Officer |
• – – |
2015-02-10 |
4 |
S |
$171.15 |
$55,624 |
D/D |
(325) |
5,213 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Marketing Officer |
• – – |
2015-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,538 |
5,538 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Chief Marketing OfficerOf |
• – – |
2015-02-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,000 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
